Skip to content

Sustainability

Made responsibly, delivered sustainably

A pharmaceutical manufacturer's first duty is to human health. Ours extends to the water we draw, the packaging we form, and the communities we serve.

Our Approach

Three commitments that guide every decision

Environment

Responsible by design

Recyclable polypropylene packaging, efficient ISBM production and careful stewardship of the natural spring water that flows into every bottle.

Social

Health for the nation

Affordable, life-saving therapies for more than 2,700 hospitals — strengthening Indonesia's pharmaceutical independence.

Governance

Built on integrity

PIC/S-aligned quality governance, transparent operations and disciplined management as we prepare for the public markets.

In Practice

Commitments, itemized

Environment

  • Recyclable polypropylene primary packaging
  • ISBM production with 40–50% cost- and resource-efficiency gains
  • Energy-efficiency programs across production lines and utilities
  • Responsible stewardship of natural spring water sources
  • Waste reduction programs across plant operations

Social

  • Affordable therapies supporting ~50% of national infusion needs
  • Strengthening Indonesia's pharmaceutical independence
  • Skilled employment and professional development in East Java
  • Reliable supply to 2,700+ hospitals, including remote regions

Governance

  • PIC/S-aligned quality governance
  • Transparent, audited operations under BPOM RI oversight
  • Disciplined financial management ahead of a planned IPO
  • Ethical sourcing and supplier standards

The Road Ahead

An ESG roadmap that scales with us

Sustainability at Satoria Pharma is staged deliberately — each phase building the systems the next one reports against.

Now

Efficient by design

Recyclable PP packaging, ISBM material efficiency, water stewardship and plant-wide waste reduction — sustainability embedded in how we already manufacture.

Next

Measure and reduce

Energy monitoring across lines and utilities, waste-reduction targets supported by our next-generation SVP manufacturing platform, and an internal ESG reporting baseline.

Future

Report and lead

Formal ESG disclosures aligned with public-market expectations as we approach our planned IPO — with renewable energy adoption on the evaluation path.

Sustainability | Satoria Pharma